Involvement of matrix metalloproteinase-13 in stromal-cell-derived factor 1α-directed invasion of human basal cell carcinoma cells

Oncogene

Volumn 26, Issue 17, 2007, Pages 2491-2501

  Chu, C Y ^a,b   Cha, S T ^b   Chang, C C ^b   Hsiao, C H ^a   Tan, C T ^a   Lu, Y C ^a,b   Jee, S H ^a,b   Kuo, M L ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Basal cell carcinoma; Collagenase 3; CXCR4; Invasion; MMP 13; SDF 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; COLLAGENASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C JUN; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BASAL CELL CARCINOMA; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR MECHANICS; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR RECURRENCE; UPREGULATION;

CARCINOMA, BASAL CELL; CELL LINE, TUMOR; CHEMOKINES, CXC; HUMANS; MATRIX METALLOPROTEINASE 13; NEOPLASM INVASIVENESS; RECEPTORS, CXCR4;

MUS MUSCULUS;

EID: 34247130586     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210040     Document Type: Article

References (54)

1. Airola K, Johansson N, Kariniemi AL, Kähäri VM, Saarialho-Kere UK. (1997). Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 109: 225-231.
2. Ala-aho R, Kähäri VM. (2005). Collagenases in cancer. Biochimie 87: 273-286.
3. Avniel S, Arik Z, Maly A, Sagie A, Basst HB, Yahana MD et al. (2006). Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol 126: 468-476.
4. Bachelder RE, Wendt MA, Mercurio AM. (2002). Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62: 7203-7206.
5. Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T et al. (2001). Stromal cell-derived factor-1α induces astrocyte proliferation through the activation of extracellular signalregulated kinases 1/2 pathway. J Neurochem 77: 1226-1236.
6. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL et al. (2003). Stromal cell-derived factor 1α stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 63: 1969-1974.
7. Bartolomé RA, Gálvez BG, Longo N, Baleux F, van Muijen GNP, Sánchez-Mateos P et al. (2004). Stromal cell-derived factor-1α promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities. Cancer Res 64: 2534-2543.
8. Bartolomé RA, Molina-Ortiz I, Samaniego R, Sánchez-Mateos P, Bustelo XR, Teixido J. (2006). Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion. Cancer Res 66: 248-258.
9. Brand S, Dambacher J, Beigel F, Olszak T, Diebold J, Otte JM et al. (2005). CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 310: 117-130.
10. Burger JA, Kipps TJ. (2006). CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107: 1761-1767.
11. Chen GS, Yu HS, Lan CCE, Chow KC, Lin TY, Kok LF et al. (2006). CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma. Br J Dermatol 154: 910-918.
12. De Clercq E. (2003). The bicyclam AMD3100 story. Nat Rev Drug Discov 2: 581-587.
13. Dignam JD, Lebovitz RM, Roeder RG. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489.
14. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. (1997). Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
15. Dumas V, Kanitakis J, Charvat S, Euvrard S, Faure M, Claudy A. (1999). Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas. Anticancer Res 19: 2929-2938.
16. Eferl R, Wagner EF. (2003). AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868.
17. Egeblad M, Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
18. Fernandis AZ, Prasad A, Band H, Klösel R, Ganju RK. (2004). Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23: 157-167.
19. Forsyth CB, Pulai J, Loeser RF. (2002). Fibronectin fragments and blocking antibodies to α2β1 and α5β1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum 46: 2368-2376.
20. Hatse S, Princen K, Bridger G, De Clercq E, Schols D. (2002). Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 527: 255-262.
21. Jee SH, Chiu HC, Tsai TF, Tsai WL, Liao YH, Chu CY et al. (2002). The phosphatidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells. J Invest Dermatol 119: 1121-1127.
22. Jee SH, Chu CY, Chiu HC, Huang YL, Tsai WL, Liao YH et al. (2004). Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways. J Invest Dermatol 123: 1169-1175.
23. Jiménez MJG, Balbín M, López JM, Alvarez J, Komori T, López-Otín C. (1999). Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19: 4431-4442.
24. Kerkelä E, Saarialho-Kere U. (2003). Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 12: 109-125.
25. Kijima T, Maulik G, Ma PC, Tibaldi EV, Turner RE, Rollins B et al. (2002). Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res 62: 6304-6311.
26. Lapteva N, Yang AG, Sanders DE, Strube RW, Chen SY. (2005). CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther 12: 84-89.
27. Lear JT, Harvey I, de Berker D, Strange RC, Fryer AA. (1998). Basal cell carcinoma. J R Soc Med 91: 585-588.
28. Leeman MF, Curran S, Murray GI. (2002). The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol 37: 149-166.
29. Menu E, Asosingh K, Indraccolo S, de Raeve H, van Riet I, van Valckenborgh E et al. (2006). The involvement of stromal derived factor 1α in homing and progression of multiple myeloma in the 5TMM model. Haematologica 91: 605-612.
30. Mueller MM, Fusenig NE. (2004). Friends or foes -bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849.
31. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
32. Murphy PM. (1996). Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev 7: 47-64.
33. Neuhaus T, Stier S, Totzke G, Gruenewald E, Fronhoffs S, Sachinidis A et al. (2003). Stromal cell-derived factor 1α (SDF-1α) induces gene-expression of early growth response (Erg-1) and VEGF in human arterial endothelial cells and enhances VEGF induced cell proliferation. Cell Prolif 36: 75-86.
34. Ohira S, Sasaki M, Harada K, Sato Y, Zen Y, Isse K et al. (2006). Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-α and stromal-derived factor-1 released in stroma. Am J Pathol 168: 1155-1168.
35. Payne AS, Cornelius LA. (2002). The role of chemokines in melanoma tumor growth and metastasis. J Invest Dermatol 118: 915-922.
36. Pendás AM, Balbín M, Llano E, Jiménez MG, López-Otín C. (1997). Structural analysis and promoter characterization of the human collagenase-3 gene (MMP-13). Genomics 40: 222-233.
37. Pendás AM, Uría JA, Jiménez MG, Balbín M, Freije JP, López-Otín C. (2000). An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies. Clin Chim Acta 291: 137-155.
38. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, Strieter RM. (2003). The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167: 1676-1686.
39. Poulsom R, Hanby AM, Pignatelli M, Jeffery RE, Longcroft JM, Rogers L et al. (1993). Expression of gelatinase A and TIMP-2 mRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J Clin Pathol 46: 429-436.
40. Rippey JJ. (1998). Why classify basal cell carcinomas? Histopathology 32: 393-398.
41. Saur D, Seidler B, Schneider G, Algül H, Beck R, Senekowitsch-Schmidtke R et al. (2005). CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology 129: 1237-1250.
42. Singh S, Singh UP, Grizzle WE, Lillard Jr JW. (2004). CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest 84: 1666-1676.
43. Strieter RM. (2001). Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nat Immunol 2: 285-286.
44. Uría JA, Jiménez MG, Balbín M, Freije JMP, López-Otín C. (1998). Differential effects of transforming growth factor-β on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J Biol Chem 273: 9769-9777.
45. Uría JA, Ståhle-Bäckdahl M, Seiki M, Fueyo A, López-Otín C. (1997). Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res 57: 4882-4888.
46. Varani J, Hattori Y, Chi Y, Schmidt T, Perone P, Zeigler ME et al. (2000). Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin. Br J Cancer 82: 657-665.
47. Walling HW, Fosko SW, Geraminejad PA, Whitaker DC, Arpey CJ. (2004). Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metast Rev 23: 389-402.
48. Woodhouse EC, Chuaqui RF, Liotta LA. (1997). General mechanisms of metastasis. Cancer 80: 1529-1537.
49. Yen HT, Chiang LC, Wen KH, Tsai CC, Yu CL, Yu HS. (1996). The expression of cytokines by an established basal cell carcinoma cell line (BCC-1/KMC) compared with cultured normal keratinocytes. Arch Dermatol Res 288: 157-161.
50. Yucel T, Mutnal A, Fay K, Fligiel SEG, Wang T, Johnson T et al. (2005). Matrix metalloproteinase expression in basal cell carcinoma: relationship between enzyme profile and collagen fragmentation pattern. Exp Mol Pathol 79: 151-160.
51. Zhang J, Sarkar S, Yong VW. (2005). The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis 26: 2069-2077.
52. Zhang S, Liu J, MacGibbon G, Dragunow M, Cooper GJS. (2002). Increased expression and activation of c-Jun contributes to human amylin-induced apoptosis in pancreatic islet β-cells. J Mol Biol 324: 271-285.
53. Zhou Y, Larsen PH, Hao C, Yong VW. (2002). CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277: 49481-49487.
54. Zlotnik A, Yoshie O. (2000). Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127.